Eligibility criteria
Condition
Healthy Subjects
Sex
Females and Males
Age
18-64 years
Inclusion criteria
Show details
- Healthy Volunteers aged 18-64
Exclusion criteria
Show details
- Bleeding disorder
You are here
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
NCT00401232
Last updated on November 18, 2019
About this Study
This is a study to collect blood from volunteers to assist in assay development.
NCT00401232
Pfizer
Active, not recruiting
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Based on your search, you may also be interested in
Healthy Subjects
NCT03762928
All Genders
18+
Years
New Haven, Connecticut
Healthy Subjects
NCT03492697
All Genders
18+
Years
New Haven, Connecticut
Healthy Subjects
NCT03230383
All Genders
18+
Years
Multiple Sites
Healthy Subjects
NCT03309241
All Genders
18+
Years
New Haven, Connecticut
| Descriptive Information | ||||
|---|---|---|---|---|
| Brief Title ICMJE | Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development | |||
| Official Title ICMJE | Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development | |||
| Brief Summary | This is a study to collect blood from volunteers to assist in assay development. | |||
| Detailed Description | Not Provided | |||
| Study Type ICMJE | Interventional | |||
| Study Phase ICMJE | Not Applicable | |||
| Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Single Group Assignment Primary Purpose: Diagnostic | |||
| Condition ICMJE | Healthy Subjects | |||
| Intervention ICMJE | Procedure: Blood Collection Blood Collection | |||
| Study Arms ICMJE | Arm 1 Intervention: Procedure: Blood Collection | |||
| Publications * | Not Provided | |||
| * Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
| Recruitment Information | ||||
| Recruitment Status ICMJE | Completed | |||
| Actual Enrollment ICMJE | 955 | |||
| Original Enrollment ICMJE | Not Provided | |||
| Actual Study Completion Date ICMJE | December 2017 | |||
| Actual Primary Completion Date | December 2017 (Final data collection date for primary outcome measure) | |||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
| Sex/Gender ICMJE |
| |||
| Ages ICMJE | 18 Years to 64 Years (Adult) | |||
| Accepts Healthy Volunteers ICMJE | Yes | |||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
| Listed Location Countries ICMJE | United States | |||
| Removed Location Countries | ||||
| Administrative Information | ||||
| NCT Number ICMJE | NCT00401232 | |||
| Other Study ID Numbers ICMJE | 6108A1-800 B1971032 ( Other Identifier: Alias Study Number ) | |||
| Has Data Monitoring Committee | No | |||
| U.S. FDA-regulated Product | Not Provided | |||
| IPD Sharing Statement ICMJE | Not Provided | |||
| Responsible Party | Pfizer | |||
| Study Sponsor ICMJE | Pfizer | |||
| Collaborators ICMJE | Not Provided | |||
| Investigators ICMJE |
| |||
| PRS Account | Pfizer | |||
| Verification Date | March 2018 | |||
| ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP | ||||
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
BY PHONE
Pfizer Clinical Trials Contact Center
1-800-718-1021